Insider Transactions in Q1 2025 at Abeona Therapeutics Inc. (ABEO)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Jan 31
2025
|
Mark Alvino Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+26.44%
|
-
|
Jan 31
2025
|
Leila Alland Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+18.95%
|
-
|
Jan 31
2025
|
Bernhardt G Zeiher Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+43.37%
|
-
|
Jan 31
2025
|
Eric Crombez Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+43.37%
|
-
|
Jan 31
2025
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+21.28%
|
-
|
Jan 31
2025
|
Donald A. Wuchterl Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+19.34%
|
-
|
Jan 31
2025
|
Michael Amoroso Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+16.67%
|
-
|
Jan 31
2025
|
Faith L. Charles Director |
BUY
Grant, award, or other acquisition
|
Direct |
36,101
+19.42%
|
-
|
Jan 29
2025
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
4,000
-5.85%
|
$20,000
$5.38 P/Share
|
Jan 21
2025
|
Vishwas Seshadri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
476,435
+25.66%
|
-
|
Jan 21
2025
|
Joseph Walter Vazzano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
144,509
+22.09%
|
-
|
Jan 21
2025
|
Brendan M. O'Malley SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
115,607
+22.92%
|
-
|
Jan 21
2025
|
Mark Alvino Director |
SELL
Open market or private sale
|
Direct |
4,000
-5.53%
|
$20,000
$5.1 P/Share
|